Celltrion, Inc. & Celltrion Healthcare Co., Ltd. Announce Shareholders Approval of Merger
Retrieved on:
Monday, October 23, 2023
Research, Finance, Professional Services, Biotechnology, Health, Pharmaceutical, General Health, Other Professional Services, Science, Retirement, Celltrion, FDA, Treasury, E-GMS, News, Sheraton Grand Incheon Hotel, Canopy Growth, Songdo Convensia, Acquisition, KRW, Multimedia, Pharmaceutical industry, Security (finance), Retail
Celltrion Group announced that the merger agreement between Celltrion, Inc. (KRX:068270) (“Celltrion”) and Celltrion Healthcare Co., Ltd. (KOSDAQ:091990) (“Celltrion Healthcare”) was approved at the extraordinary general meeting of shareholders (“EGM”) of the two companies held at Songdo Convensia and Sheraton Grand Incheon Hotel, respectively, on October 23, 2023.
Key Points:
- Celltrion Group announced that the merger agreement between Celltrion, Inc. (KRX:068270) (“Celltrion”) and Celltrion Healthcare Co., Ltd. (KOSDAQ:091990) (“Celltrion Healthcare”) was approved at the extraordinary general meeting of shareholders (“EGM”) of the two companies held at Songdo Convensia and Sheraton Grand Incheon Hotel, respectively, on October 23, 2023.
- Under the merger plan, Celltrion will merge Celltrion Healthcare and issue Celltrion shares to Celltrion Healthcare shareholders.
- Celltrion Healthcare shareholders will receive 0.4492620 shares of Celltrion for each Celltrion Healthcare share they own.
- The merger price per share is KRW 148,853 for Celltrion and KRW 66,874 for Celltrion Healthcare.